↓ Skip to main content

Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm

Overview of attention for article published in AMA Journal of Ethics, November 2022
Altmetric Badge

Mentioned by

twitter
11 tweeters
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm
Published in
AMA Journal of Ethics, November 2022
DOI 10.1001/amajethics.2022.1063
Pubmed ID
Authors

Kevin Schulman, Barak Richman

Abstract

Negative health consequences stemming from the financial burden of care on patients and their loved ones are documented as financial toxicity in the literature, and these consequences should be included in informed consent discussions during patient-clinician interactions. However, codes of medical ethics have yet to require obtaining consent to financial costs, even as the No Surprises Act, effective on January 1, 2022, requires some clinicians to facilitate informed financial consent prior to an out-of-network elective service as a means of avoiding arbitration. This article discusses how this requirement can be more broadly applied to informed consent for any intervention.

Twitter Demographics

The data shown below were collected from the profiles of 11 tweeters who shared this research output. Click here to find out more about how the information was compiled.